Weight Loss Injections: Is Tirzepatide the Right Choice for You?

How the mechanism actually changes what tirzepatide feels like to use

Most weight-loss injections work through one pathway. Tirzepatide works through two: it activates both GIP and GLP-1 receptors, which together slow gastric emptying, reduce appetite signals in the brain and help regulate blood sugar. The practical result, for many people, is a more pronounced reduction in hunger than they experience with single-pathway medicines.

The injection itself is subcutaneous (just under the skin) using a pre-filled KwikPen. You rotate between the abdomen, thigh and upper arm from week to week. If you want a clear walkthrough of the technique before your first dose, the guide to using tirzepatide for weight loss covers it step by step.

The starter dose, 2.5 mg, exists primarily to let your system adjust. Its job is tolerability, not treatment, most of the weight-reduction effect builds as your prescriber titrates through 5, 7.5, 10, 12.5 and up to 15 mg over subsequent months. If you want to understand exactly how each strength is introduced and what to expect as you move through them, the detailed guidance on how to take tirzepatide for weight loss walks through the titration process alongside practical advice for each stage. Rushing that schedule isn't something you control; it sits with the prescriber, and for good reason.

For a fuller picture of the pen itself and the strengths available, the tirzepatide weight-loss pen page goes into more detail on the KwikPen format and dose range. The NHS also publishes a patient-level overview of tirzepatide, covering mechanism, common side effects and what to tell your doctor before starting, at nhs.uk/medicines/tirzepatide.

Whether you meet the eligibility criteria, and where the grey areas sit

The licensed eligibility for tirzepatide injections in the UK is adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition. Those conditions include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea and prediabetes, among others. BMI thresholds are adjusted downward for some ethnic backgrounds under UK clinical guidance.

That said, BMI is a starting point, not a verdict. A prescriber also considers your medical history, any medicines you already take, whether you have conditions that rule tirzepatide out (certain thyroid or pancreatic histories, for example), and whether the balance of benefit and risk makes sense for you specifically. These are the conversations that happen during a clinical consultation, not a checklist a form can complete on its own.

If you're unsure where you stand, reading about Mounjaro weight loss injections alongside the eligibility detail can help you frame the right questions. People sometimes ask whether being on other medications affects suitability, the answer is that some combinations need prescriber discussion, others are fine, and a thorough consultation is the only way to get an accurate answer for your situation.

Tirzepatide is not licensed for use during pregnancy, breastfeeding or when actively trying to conceive, and it is not licensed for under-18s.

Side effects: what the evidence shows and when to get medical help

The most commonly reported side effects with tirzepatide weight loss injections are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and burping. They are typically at their most noticeable after the first dose or after stepping up to a new strength, and they ease for most people within days to a couple of weeks as the body adjusts.

More serious but less common effects include gallbladder symptoms and, rarely, acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, highlighting pancreatitis as a known risk: get urgent medical attention if you develop severe, persistent stomach pain, particularly if it reaches into your back, with or without vomiting. You can report any suspected side effect directly to the MHRA via the Yellow Card scheme.

If you are a woman using oral contraceptives, NHS guidance notes that you should add a non-oral method for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, because absorption of the pill may be reduced during that window. Discuss with your prescriber if you are also on HRT, transdermal forms are often preferred for the same reason.

A note on timing that comes up often: if you're planning surgery or a procedure, tell the anaesthetist and your surgical team that you take tirzepatide before you go in. It's easy to forget if your injection is simply part of the weekly routine. If you're ordering around a bank holiday or have a break coming up, the FAQs cover what to do if a dose is delayed, but the definitive answer always comes from your prescriber and the Patient Information Leaflet, not from a content page.

Private treatment versus the NHS, and what to weigh up

Tirzepatide is available on the NHS, but access is phased. As of summer 2026, NHS eligibility requires a BMI of 40 or above alongside four or more specific weight-related conditions, criteria that cover a relatively small group. A second cohort, with a BMI of 35 or above and four or more conditions, became eligible in June 2026. If you do not meet those thresholds, or would rather not wait, private treatment through a regulated UK pharmacy is the alternative route.

Cost is a real consideration. Since Eli Lilly raised UK list prices in September 2025, private tirzepatide injections for weight loss typically range from roughly £149 to £375 per month depending on dose and provider. The Mounjaro price page sets out the cost context honestly, including what a legitimate private price should include: consultation, clinical review, prescription, and aftercare. If you are also looking to make your treatment more affordable, our current Mounjaro injection offers are worth checking before you decide how to proceed. A headline price that skips those elements is worth scrutinising.

What matters more than the monthly figure is whether the pharmacy you use is registered with the GPhC, whether a real prescriber reviews your information, and whether the medicine you receive comes through the licensed UK supply chain. You can verify any pharmacy on the GPhC public register in under a minute. Counterfeit weight-loss pens are a genuine enforcement issue, the MHRA has carried out large-scale seizures of fake injectable medicines sold without clinical oversight, and fake pens have been found to contain other substances entirely.

If tirzepatide injections for weight loss sound right for your situation, the clearest next step is a clinical conversation. Our prescribers can assess your eligibility and answer the questions specific to your health history. You can speak to our prescribers through a free consultation, with clinical review the same day.